Page 19 - GlaxoSmithKline Pharmaceuticals AR 2012

15
• Attendance of each Director at the Board meetings and last Annual General Meeting (AGM)
and the number of companies and committees where he is a Director / Member (as on the
date of the Directors’ Report)
Name of Director Category of
Directorship
Number
of Board
Meet-
ings
attended
Atten-
dance at
the last
AGM
held on
10th April
2012
Number of
Director-
ships
in other
companies
(excluding
Director-
ships in
foreign
and private
companies)
Number of
mandatory
committee
positions held in
other companies
Chairman Member
Mr. D. S. Parekh
Chairman
Non-Executive 7 Yes 8* 1 3
Mr. V. Thyagarajan
Vice-Chairman
Non-Executive 5 Yes 1 Nil 2
Dr. H. B. Joshipura
Managing Director
Executive 7 Yes 1 Nil Nil
Mr. R. R. Bajaaj Non-Executive
& Independent
6 Yes 1 Nil Nil
Dr. A. Banerjee
(Alternate to
Mr. S. Harford)
(upto 31.07.2012)
Executive 2 N. A. Nil Nil Nil
Ms. A. Bansal
(w.e.f. 19.02.2013)
Non-Executive
& Independent
N. A. N. A. Nil Nil Nil
Mr. P. V. Bhide Non-Executive
& Independent
7 Yes 7 2 3
Mr. S. Harford Non-Executive 4 Yes Nil Nil Nil
Mr. M. B. Kapadia Executive 7 Yes 1 Nil Nil
Mr. N. Kaviratne Non-Executive
& Independent
4 No 1 Nil Nil
Mr. R. Krishnaswamy Executive 7 Yes 1 Nil Nil
Mr. V. Narayanan
(upto 9.11.2012)
Non-Executive
& Independent
5 Yes 7 4 2
Mr. P. V. Nayak Non-Executive
& Independent
7 Yes 1 Nil 1
Mr. A. N. Roy Non-Executive
& Independent
7 Yes 1 Nil Nil
Mr. R. C. Sequeira Executive 7 Yes 2 Nil Nil
Mr. D. Sundaram Non-Executive
& Independent
7 Yes 4 2 1
* In addition, Mr. D. S. Parekh is Alternate Director on 2 Public Limited Companies.
• Directors with materially significant related party transactions, pecuniary or business
relationship with the Company
There have been no materially significant related party transactions, pecuniary transactions or
relationships between the Company and its Directors that may have potential conflict with the
interests of the Company at large.